Regeneron Pharmaceuticals Inc (WBO:REGN)
€ 910.2 5.8 (0.64%) Market Cap: 99.67 Bil Enterprise Value: 92.44 Bil PE Ratio: 28.90 PB Ratio: 3.99 GF Score: 77/100

Regeneron Pharmaceuticals Inc at Evercore ISI HealthCONx Virtual Conference Transcript

Nov 30, 2021 / 02:15PM GMT
Release Date Price: €569.5 (-1.28%)
Joshua Elliott Schimmer
Evercore ISI Institutional Equities, Research Division - Senior MD & Equity Analyst

All right. Welcome, everyone, for the Regeneron session at Evercore ISI Healthcare Conference. I think Mark is going to kick us off with some quick commentary, and we are going to dive into a bunch of exciting topics, cover as much ground as we can in 20 minutes.

Mark Hudson
Regeneron Pharmaceuticals, Inc. - IR Executive

Great. Thanks, Josh, and it's great to be here. And good morning, good afternoon, everyone, joining us on today's webcast. So I'm Mark Hudson from the IR team. And joining me today is Neil Stahl and Jamie Orengo, both key scientists and R&D leaders here at Regeneron. So Neil is our Executive Vice President of R&D and one of the founding fathers of Regeneron with nearly 30 years plus at the company. And he's instrumental in some of the key technologies and ultimately, some of the drugs discovered and developed in our labs in New York. And Jamie is a VP of Research of Allergy & Immunity and one of the lead scientists and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot